Glenmark Pharmaceuticals Inc. issued a recall for some of its Potassium Chloride Extended-Release Capsules over a "failed dissolution" that may cause heart attacks.

Sutab ® (sodium sulfate, magnesium sulfate, and potassium chloride tablets; Sebela Pharmaceuticals), an osmotic laxative, is now available for cleansing of the colon in preparation for ...

Potassium (as chloride) 8mEq, 10mEq; ext-rel tabs. Take with meals and fluids. Swallow tabs whole; may break Klor-Con M tabs in half, or mix in 4oz water. Effervescent tabs, pwd: dissolve in ...

Potassium Chloride Extended Release tablets USP, 10 mEq (750 mg) and 20 mEq (1500 mg) were approved by the USFDA for treating patients with Hypokalemia.

"Glenmark Pharmaceuticals Inc, USA has been granted final approval by the US Food and Drug Administration (USFDA) for Potassium Chloride Extended Release Tablets USP, 10mEq (750 mg) and 20mEq ...

Glenmark Pharmaceuticals has received final approval from the US health regulator for Potassium Chloride Extended Release Tablets, ... AI-171 black box data extracted, analysis on.

Glenmark Pharmaceuticals has received final approval from the US health regulator for Potassium Chloride Extended Release Tablets, used for treating low levels of potassium in blood. “Glenmark ...

The Food and Drug Administration approved Glenmark Pharamceuticals' potassium chloride tablets. The tablets, used to treat a potassium deficiency, are a generic version of K Dur tablets produced ...

The Food and Drug Administration approved Glenmark Pharamceuticals’ potassium chloride tablets. Advertisement. By: Mackenzie Bean. Friday, July 29th, 2016. Print Share.

Drug Involved in Errors: Potassium chloride, a salt available in a host of generic formulations, including solutions, tablets and injectible forms. Indication: Low potassium levels, often as a ...